Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12081225
Abstract: Glioblastoma (GBM) is one of the leading lethal tumors, featuring aggressive malignancy and poor outcome to current standard temozolomide (TMZ) or radio-based therapy. Developing immunotherapies, especially immune checkpoint inhibitors, have improved patient outcomes in other… read more here.
Keywords: macrophages glioblastoma; therapy; development therapy; glioblastoma development ... See more keywords